Cargando…
Tackling HLA Deficiencies Head on with Oncolytic Viruses
SIMPLE SUMMARY: Oncolytic viruses show great promise as anticancer agents by simultaneously lysing cancer cells while stimulating innate and adaptive immune responses. However, the extent to which the adaptive immune system contributes to overall efficacy alongside oncolytic viruses is, in part, dep...
Autores principales: | Fisher, Kerry, Hazini, Ahmet, Seymour, Leonard W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916504/ https://www.ncbi.nlm.nih.gov/pubmed/33578735 http://dx.doi.org/10.3390/cancers13040719 |
Ejemplares similares
-
Deregulation of HLA-I in cancer and its central importance for immunotherapy
por: Hazini, Ahmet, et al.
Publicado: (2021) -
Oncolytic viruses: finally delivering
por: Seymour, Leonard W, et al.
Publicado: (2016) -
Coxsackievirus B3—Its Potential as an Oncolytic Virus
por: Geisler, Anja, et al.
Publicado: (2021) -
Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus
por: Wan, Peter Kok-Ting, et al.
Publicado: (2021) -
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
por: Hazini, Ahmet, et al.
Publicado: (2021)